ADDvise receives order worth USD 1.7 million
ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from BioGeneric Pharma, a leading factory in biotechnology based in Cairo, Egypt. The order is worth approximately USD 1.7 million. The order is an add-on-project in the ongoing project between the parties regarding design, supply, and commissioning of clean room environment to be used for production of mRNA-vaccine. BioGeneric Pharma has been selected by the World Health Organization (WHO) to be the first technology transfer recipient of mRNA-vaccine hub in Egypt for distribution in Africa. Delivery of the order is planned